Any current/future new fundraising through debt or equity?

Currently, India Pesticides Limited has not taken any term loans and all capex is funded through internal accruals. For future expansions, especially for the domestic market, the company plans to continue funding primarily via internal accruals. However, for their 100% subsidiary, they may take nominal debt in future years. There is no mention of any current or planned fundraising through equity in the provided transcript. Overall, the company is focusing on organic growth and internal funds for capex with limited reliance on external debt.

Any current/future capex/capital investment/strategic investment?

India Pesticides is executing a capex plan focused on new molecules, especially at the Hamirpur plant. INR 50 crores capex is planned annually for Hamirpur, building blocks progressively (2 blocks planned in FY '26, targeting 10-12 blocks long-term). Initial asset turn at Hamirpur expected around 1 due to investment in greenfield infrastructure; improves with subsequent blocks. Sandila plant nearing saturation; capacity utilization being optimized by changing product mix. Capex is primarily funded through internal accruals; potential nominal debt for 100% subsidiary in future. New products are

Future growth expectations in sales/revenue/volumes?

The company expects a revenue growth of 15% to 20% in FY '26 driven by volume increase and new product additions. Volume growth has been around 30%, which is a plus point for achieving revenue targets. Domestic market shows better volume growth compared to export markets. Capacity utilization can improve to around 85% with demand growth, supporting higher revenues (potential to reach INR1,100 crores with current infrastructure). Capex in Hamirpur is expected to add incremental revenue of about INR60-70 crores per block, with 2 blocks planned in FY '26 and 10-12 blocks long-term. Marg

Future growth expectations in earnings/operating earnings/profits/EPS?

India Pesticides expects **15% to 20% revenue growth** for FY '26 driven by volume increase and new product introductions. EBITDA margins are targeted to stabilize around **16% to 18%** in the near term (next 2-3 quarters), with no major downward trend expected. Volume growth of around **30%** has been achieved, supporting revenue expansion. New capacity additions, especially at the Hamirpur facility, are expected to start contributing from FY '26, enhancing future earnings potential. The company expects incremental revenue of about **INR 60-70 crores per block** from capex investments

Current/ Expected Orderbook/ Pending Orders?

The company is experiencing short-term order commitments, with customers preferring 1 to 2 months orders rather than long-term forecasts of 6 to 12 months due to market volatility. This short-term ordering is considered beneficial for both seller and buyer amid fluctuating prices (Page 19). Inventory buildup for certain products (e.g., a major herbicide) has been ongoing for about 4 months to meet upcoming seasonal demand, indicating upcoming supply deliveries (Page 19 and Page 20). The company has started receiving good orders for these products in Q4 (Page 20). There is ongoing signi

India Pesticides LtdQ4 FY25

India Pesticides Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹141P/E: 15.6Market Cap: ₹1.7K Cr

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company expects a revenue growth of 15% to 20% in FY '26 driven by volume increase and new product additions.
→Volume growth has been around 30%, which is a plus point for achieving revenue targets.
→Domestic market shows better volume growth compared to export markets.
→Capacity utilization can improve to around 85% with demand growth, supporting higher revenues (potential to reach INR1,100 crores with current infrastructure).
→Capex in Hamirpur is expected to add incremental revenue of about INR60-70 crores per block, with 2 blocks planned in FY '26 and 10-12 blocks long-term.
→Margins are expected to stabilize around 16%-18% EBITDA in the near term.
→New molecules from ongoing capex should start contributing from FY '26 onwards.
→Short-term export demand remains subdued but stable; domestic demand remains strong.

Margin guidance

Category 3

→India Pesticides expects **15% to 20% revenue growth** for FY '26 driven by volume increase and new product introductions.
→EBITDA margins are targeted to stabilize around **16% to 18%** in the near term (next 2-3 quarters), with no major downward trend expected.
→Volume growth of around **30%** has been achieved, supporting revenue expansion.
→New capacity additions, especially at the Hamirpur facility, are expected to start contributing from FY '26, enhancing future earnings potential.
→The company expects incremental revenue of about **INR 60-70 crores per block** from capex investments, adding to growth.
→No major increase in debt is planned; capex is primarily funded through internal accruals, supporting healthy balance sheet and free cash flow.
→Pricing pressure remains but is expected to be stable, not further eroding margins significantly.

3 more insights locked — sign up free to unlock

Fundraise plans

→Currently, India Pesticides Limited has not taken any term loans and all capex is funded through internal accruals.
→For future expansions, especially for the domestic market, the company plans to continue funding primarily via internal accruals.
→However, for their 100% subsidiary, they may take nominal debt in future years.
→There is no mention of any current or planned fundraising through equity in the provided transcript.
→Overall, the company is focusing on organic growth and internal funds for capex with limited reliance on external debt.

Order book

→The company is experiencing short-term order commitments, with customers preferring 1 to 2 months orders rather than long-term forecasts of 6 to 12 months due to market volatility.
→This short-term ordering is considered beneficial for both seller and buyer amid fluctuating prices (Page 19).
→Inventory buildup for certain products (e.g., a major herbicide) has been ongoing for about 4 months to meet upcoming seasonal demand, indicating upcoming supply deliveries (Page 19 and Page 20).
→The company has started receiving good orders for these products in Q4 (Page 20).
→There is ongoing signing of contracts, e.g., a 3-year supply contract for intermediates with Japanese companies (Page 15).
→No explicit numeric current orderbook or pending order value is mentioned, but volumes and sales are expected to grow with new capacities coming online and the company targeting 15%-20% revenue growth next year (Pages 14-15).

Capex plans

Yes

→India Pesticides is executing a capex plan focused on new molecules, especially at the Hamirpur plant.
→INR 50 crores capex is planned annually for Hamirpur, building blocks progressively (2 blocks planned in FY '26, targeting 10-12 blocks long-term).
→Initial asset turn at Hamirpur expected around 1 due to investment in greenfield infrastructure; improves with subsequent blocks.
→Sandila plant nearing saturation; capacity utilization being optimized by changing product mix.
→Capex is primarily funded through internal accruals; potential nominal debt for 100% subsidiary in future.
→New products are expected to start contributing from FY '26, especially from Hamirpur.
→Ongoing investment improving infrastructure, workforce capabilities, R&D initiatives, and advanced technologies to boost specialty product capabilities and expand market reach.

How does India Pesticides Ltd rank vs peers in ?

Pro feature

1India Pesticides Ltd

Rev 3Mar 3

See full sector rankings

Want more stocks like India Pesticides Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio